Torrent Pharmaceuticals Limited (BOM:500420)

Torrent Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 21, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	1,347,876	1,094,736	880,347	520,309	473,197	430,029
Market Cap Growth	15.56%	24.35%	69.20%	9.96%	10.04%	28.90%
Enterprise Value	1,368,156	1,113,646	917,337	553,029	510,577	476,479
Last Close Price	3982.55	3228.47	2570.72	1500.31	1341.02	1201.04
PE Ratio	62.98	57.28	53.15	41.78	60.89	34.35
Forward PE	48.01	43.21	43.79	35.81	31.03	34.20
PS Ratio	11.00	9.51	8.21	5.41	5.56	5.37
PB Ratio	15.95	14.42	12.84	8.40	7.95	7.37
P/TBV Ratio	33.15	36.63	45.49	67.48	22.04	28.47
P/FCF Ratio	99.24	55.48	31.07	29.00	29.57	25.75
P/OCF Ratio	69.47	42.35	26.95	21.97	26.25	21.44
PEG Ratio	2.54	1.90	1.82	1.94	2.34	2.11
EV/Sales Ratio	11.17	9.67	8.55	5.75	6.00	5.95
EV/EBITDA Ratio	34.44	30.30	27.59	19.73	21.43	19.62
EV/EBIT Ratio	42.92	38.06	35.66	25.84	28.86	26.14
EV/FCF Ratio	100.73	56.44	32.38	30.82	31.90	28.53
Debt / Equity Ratio	0.33	0.43	0.59	0.87	0.69	0.84
Debt / EBITDA Ratio	0.71	0.88	1.21	1.92	1.70	2.00
Debt / FCF Ratio	2.08	1.65	1.43	3.02	2.57	2.95
Asset Turnover	0.80	0.77	0.71	0.68	0.63	0.57
Inventory Turnover	1.26	1.15	1.19	1.17	0.95	0.89
Quick Ratio	0.67	0.62	0.59	0.54	0.56	0.54
Current Ratio	1.40	1.19	1.03	0.98	1.20	1.13
Return on Equity (ROE)	26.83%	26.46%	25.38%	20.50%	13.18%	23.49%
Return on Assets (ROA)	13.02%	12.17%	10.69%	9.52%	8.14%	8.11%
Return on Invested Capital (ROIC)	22.93%	20.88%	17.43%	14.16%	11.50%	14.92%
Return on Capital Employed (ROCE)	28.80%	28.50%	26.70%	22.40%	20.40%	19.80%
Earnings Yield	1.59%	1.75%	1.88%	2.39%	1.64%	2.91%
FCF Yield	1.01%	1.80%	3.22%	3.45%	3.38%	3.88%
Dividend Yield	0.80%	0.99%	1.09%	1.47%	1.23%	1.46%
Payout Ratio	50.60%	56.67%	61.30%	41.21%	87.10%	27.03%
Total Shareholder Return	0.80%	0.99%	1.09%	1.47%	1.23%	1.46%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.